Breaking News Instant updates and real-time market news.

RIGL

Rigel Pharmaceuticals

$2.50

-0.12 (-4.58%)

08:05
06/19/17
06/19
08:05
06/19/17
08:05

Rigel sees PDUFA date of April 17, 2018 for Tavalisse in chronic ITP

RIGL Rigel Pharmaceuticals
$2.50

-0.12 (-4.58%)

09/16/16
JEFF
09/16/16
NO CHANGE
Target $9
JEFF
Buy
Jefferies views Rigel restructuring positively, ups target to $9
Jefferies analyst Eun Yang views Rigel Pharmaceuticals' restructuring, which prioritizes fostamatinib commercialization while reducing research workforce, as a positive. The analyst notes the move will have no impact on the company's early programs. She raised her price target for Rigel shares to $9 from $8.50 and keeps a Buy rating on the name. Rigel closed yesterday up 4c to $3.45. The next major catalyst for the stock will be second Phase 3 data for fostamatinib in Immune Thrombocytopenic Purpura in October or November, Yang tells investors in a research note. She expects additional indications opportunities to drive "meaningful share price appreciation."
10/20/16
JPMS
10/20/16
NO CHANGE
JPMS
Overweight
Rigel has 20%-40% near-term downside, says JPMorgan
JPMorgan analyst Anupam Rama believes shares of Rigel Pharmaceuticals now have a regulatory uncertainty overhang after the company's second phase 3 trial of fostamatinib in immune thrombocytopenic missed statistical significance on its primary endpoint.There could ultimately be a registration path forward with combined phase 3 dataset, however, Rama tells investors in a research note. Nonetheless, the analyst sees the potential for 20%-40% share downside in the near-term. Rama has an Overweight rating on Rigel. The stock is down 34% to $2.11 in pre-market trading.
10/20/16
PIPR
10/20/16
NO CHANGE
PIPR
Overweight
Rigel Pharmaceuticals risk/reward remains favorable, says Piper Jaffray
With the stock down nearly 35% in pre-market trading, Piper Jaffray analyst Joshua Schimmer believes the risk/reward on shares of Rigel Pharmaceuticals remains favorable. The company on the conference call did an "excellent job" explaining the failed second Phase III results for fostamatinib in immune thrombocytopenic, Schimmer tells investors in a research note. He believes the drug has a "clear therapeutic benefit" and reiterates an Overweight rating on the stock with an $11 price target.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.

TODAY'S FREE FLY STORIES

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$279.60

0.46 (0.16%)

12:36
01/19/18
01/19
12:36
01/19/18
12:36
Periodicals
Trump seeks meeting with Schumer to avert shutdown, NY Times reports »

Maggie Haberman of the…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$279.60

0.46 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:31
01/19/18
01/19
12:31
01/19/18
12:31
Hot Stocks
Breaking Hot Stocks news story on NuCana »

NuCana resumes, up 43% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.49

0.35 (0.13%)

, IEMG

iShares Core MSCI Emerging Markets

$60.61

0.305 (0.51%)

12:30
01/19/18
01/19
12:30
01/19/18
12:30
Technical Analysis
On The Fly: ETF fund flow highlights »

Flows continued to be…

SPY

SPDR S&P 500 ETF Trust

$279.49

0.35 (0.13%)

IEMG

iShares Core MSCI Emerging Markets

$60.61

0.305 (0.51%)

IEFA

iShares Core MSCI EAFE ETF

$69.52

0.215 (0.31%)

EWJ

iShares MSCI Japan Index Fund

$63.74

0.31 (0.49%)

BNDX

Vanguard Total International Bond ETF

$54.18

-0.02 (-0.04%)

EEM

MSCI Emerging Markets Index

$50.31

0.2775 (0.55%)

IWM

iShares Trust Russell 2000 Index Fund

$157.91

1.37 (0.88%)

GLD

SPDR Gold Trust

$126.65

0.79 (0.63%)

SVXY

ProShares Short VIX Short-Term Futures

$131.85

-0.45 (-0.34%)

IWD

iShares Russell 1000 Value

$128.57

0.09 (0.07%)

JNK

SPDR Barclays High Yield Bond

$36.80

-0.015 (-0.04%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$119.83

-0.315 (-0.26%)

IEF

iShares 7-10 Year Treasury Bond ETF

$104.06

-0.33 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:30
01/19/18
01/19
12:30
01/19/18
12:30
Hot Stocks
Breaking Hot Stocks news story on NuCana »

NuCana PLC (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$162.44

-6.68 (-3.95%)

, AXP

American Express

$97.11

-2.75 (-2.75%)

12:29
01/19/18
01/19
12:29
01/19/18
12:29
General news
On The Fly: Top stock stories at midday »

Stocks opened with minor…

IBM

IBM

$162.44

-6.68 (-3.95%)

AXP

American Express

$97.11

-2.75 (-2.75%)

GE

General Electric

$16.35

-0.425 (-2.53%)

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

BIIB

Biogen

$344.44

-0.43 (-0.12%)

NKE

Nike

$66.64

2.525 (3.94%)

IPHI

Inphi

$33.39

-2.01 (-5.68%)

MKC

McCormick

$98.72

-4.19 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 07

    Feb

  • 08

    Mar

EA

Electronic Arts

$115.28

2.14 (1.89%)

, ATVI

Activision Blizzard

$69.80

-0.56 (-0.80%)

12:28
01/19/18
01/19
12:28
01/19/18
12:28
Hot Stocks
EA in focus after NPD says 'Battlefront II' second-best selling game in December »

Shares of Electronic Arts…

EA

Electronic Arts

$115.28

2.14 (1.89%)

ATVI

Activision Blizzard

$69.80

-0.56 (-0.80%)

TTWO

Take-Two

$117.27

1.18 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 30

    Jan

  • 08

    Feb

  • 21

    Feb

  • 22

    Feb

  • 07

    Dec

12:25
01/19/18
01/19
12:25
01/19/18
12:25
General news
Treasury's $25 M 6-day CMB stopped at 1.210% »

Treasury's $25 M…

BHGE

Baker Hughes

$34.63

-0.11 (-0.32%)

12:20
01/19/18
01/19
12:20
01/19/18
12:20
Options
Put buying in Baker Hughes ahead of earnings »

Put buying in Baker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.70

0.55 (3.63%)

12:19
01/19/18
01/19
12:19
01/19/18
12:19
Hot Stocks
Breaking Hot Stocks news story on Momenta 

Momenta trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
01/19/18
01/19
12:17
01/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASFI

Asta Funding

$7.35

0.05 (0.68%)

12:16
01/19/18
01/19
12:16
01/19/18
12:16
Hot Stocks
Asta Funding receives Nasdaq non-compliance letter »

Asta Funding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:16
01/19/18
01/19
12:16
01/19/18
12:16
Hot Stocks
NuCana to resume trading at 12:30 pm ET »

NuCana is scheduled to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/19/18
01/19
12:16
01/19/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.15

-0.35 (-2.26%)

12:15
01/19/18
01/19
12:15
01/19/18
12:15
Hot Stocks
Breaking Hot Stocks news story on Momenta »

Momenta jumps 14%, halted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$14.27

0.18 (1.28%)

12:15
01/19/18
01/19
12:15
01/19/18
12:15
Options
MiMedx put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.15

-0.35 (-2.26%)

12:14
01/19/18
01/19
12:14
01/19/18
12:14
Periodicals
Breaking Periodicals news story on Momenta »

Momenta weighing options,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.15

-0.35 (-2.26%)

12:14
01/19/18
01/19
12:14
01/19/18
12:14
Hot Stocks
Breaking Hot Stocks news story on Momenta »

Momenta trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$26.50

-0.31 (-1.16%)

12:05
01/19/18
01/19
12:05
01/19/18
12:05
Options
NRG Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMNB

American National Bankshares

$39.10

-0.8 (-2.01%)

12:03
01/19/18
01/19
12:03
01/19/18
12:03
Hot Stocks
American National Bankshares announces 300,000 share repurchase program »

American National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBIB

Porter Bancorp

$13.76

0.06 (0.44%)

12:02
01/19/18
01/19
12:02
01/19/18
12:02
Hot Stocks
PBI Bank changes name to Limestone Bank »

In the first weeks of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:01
01/19/18
01/19
12:01
01/19/18
12:01
Hot Stocks
NuCana reports 'promising' clinical data on Acelarin »

NuCana announced interim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

11:55
01/19/18
01/19
11:55
01/19/18
11:55
Hot Stocks
Breaking Hot Stocks news story on NuCana »

NuCana PLC (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$46.51

-0.27 (-0.58%)

11:55
01/19/18
01/19
11:55
01/19/18
11:55
Options
Mylan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 08

    Mar

BTC

Bitcoin

, BAC

Bank of America

$31.55

0.07 (0.22%)

11:52
01/19/18
01/19
11:52
01/19/18
11:52
Hot Stocks
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

BAC

Bank of America

$31.55

0.07 (0.22%)

MS

Morgan Stanley

$56.67

0.83 (1.49%)

GS

Goldman Sachs

$252.15

1.18 (0.47%)

V

Visa

$122.10

-1.015 (-0.82%)

AMD

AMD

$12.47

0.29 (2.38%)

NVDA

Nvidia

$224.44

-0.28 (-0.12%)

OSTK

Overstock.com

$71.25

-4.4 (-5.82%)

DPW

DPW Holdings

$2.30

-0.05 (-2.13%)

LBCC

Long Blockchain Corp.

$4.51

0.3 (7.13%)

KODK

Kodak

$10.05

-0.1 (-0.99%)

SSC

Seven Stars Cloud Group

$4.53

-0.1 (-2.16%)

RIOT

Riot Blockchain

$19.80

2.04 (11.49%)

LFIN

Longfin

$44.69

6.09 (15.78%)

TEUM

Pareteum

$2.37

0.01 (0.42%)

SRAX

Social Reality

$4.96

0.17 (3.55%)

GBTC

Bitcoin Investment Trust

$1,857.00

221 (13.51%)

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 30

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 15

    Feb

AOS

A.O. Smith

$66.32

0.41 (0.62%)

11:51
01/19/18
01/19
11:51
01/19/18
11:51
Hot Stocks
A.O. Smith announces 29% boost in dividend »

Directors of A. O. Smith…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.